TABLE. Distribution of identified lineages in relation to the immunisation profile of the study population.

Variant	Lineage	Complete immunisation (n = 178)	%	Partial immunisation (n = 225)	%	No immunisation (n = 137)	%	Total (n = 540)
Delta (n = 390)	B.1.617.2	9	5.1	24	10.7	12	8.8	45
	AY.4	1	0.6	2	0.9	0	0.0	3
	AY.6	0	0.0	0	0.0	1	0.7	1
	AY.9.2	6	3.4	2	0.9	2	1.5	10
	AY.34.1.1	1	0.6	0	0.0	0	0.0	1
	AY.36	0	0.0	0	0.0	1	0.7	1
	AY.39	0	0.0	0	0.0	1	0.7	1
	AY.43	59	33.1	75	33.3	45	32.8	179
	AY.43.1	0	0.0	1	0.4	0	0.0	1
	AY.46.3	1	0.6	0	0.0	0	0.0	1
	AY.99.1	1	0.6	0	0.0	0	0.0	1
	AY.99.2	74	41.6	36	16.0	29	21.2	139
	AY.101	0	0.0	1	0.4	3	2.2	4
	AY.116	0	0.0	1	0.4	0	0.0	1
	AY.122	0	0.0	0	0.0	2	1.5	2
Gamma (n = 150)	P.1	11	6.2	42	18.7	25	18.2	78
	P.1.4	6	3.4	25	11.1	10	7.3	41
	P.1.7	5	2.8	12	5.3	4	2.9	21
	P.1.11	0	0.0	1	0.4	0	0.0	1
	P.1.12	0	0.0	0	0.0	1	0.7	1
	P.1.14	4	2.2	3	1.3	1	0.7	8
Hospitalisation (n = 5)	B.1.617.2	0	0.0	1	0.5	0	0.0	1
	P.1	0	0.0	1	0.5	0	0.0	1
	P.1.4	1	1.0	0	0.0	2	1.7	3
Death (n = 4)	AY.43	0	0.6	1	0.0	0	0.0	1
	P.1	0	0.0	2	1.0	1	0.8	3

Percentage of Delta (AY.*+B.1.617.2) and Gamma (P.1.*+P.1) strains identified in relation to the immunisation profile of the study population. Individuals were classified into three distinct groups: complete immunisation (after receiving the second or third dose of the vaccine), partial immunisation (after receiving the first dose of the vaccine) or no immunisation.